Europe is struggling when it comes to advanced data use for health care purposes and innovative initiatives are needed for the region to become a leader in establishing patient-health professional networks, a guest blog posted on the Lilly in Europe website said.
One such innovative step was taken when the Collaboration for Oncology Data in Europe (CODE) project was introduced Sept. 10 at the European Society for Medical Oncology Congress, the blog said.
CODE, being led by QuintilesIMS and backed by companies such as Lilly, AstraZeneca, BMS, Merck, KGaA, Darmstadt, Germany and Pfizer, is aiming to create the Oncology Data Network (ODN) technology platform to gather data on the application of anti-cancer medications and their use in clinical practices, the blog said.
CODE and ODN may be part of the effort needed for the European oncology scene to better understand how valuable data can be in terms of improving health care, the blog said.
